Evaluation of the Function "Stop Before Hypoglycemia" on External Insulin Pump

Evaluation of the Function "Stop Before Hypoglycemia" on External Insulin Pump Coupled With the Continuous Measurement of Interstitial Glycemia in Type 1 Diabetic Adults

This study compares the apparition of hypoglycaemia in type I diabetic patients between 2 phases: the one without the use of SmartGuard® function and the one with the use of SmartGuard® function.

The aim of this study is to compare SmartGuard® function with captor and insulin pump to improve the glycemia stability in real condition.

There are several phases:

• phase 1: insulin pump without captor (12 weeks)
• phase 2: insulin pump with captor and without SmartGuard® function (4X6 days; 4 weeks)
• phase 3: insulin pump with captor and with SmartGuard® function (6X6 days; 6 weeks)
• phase 4: insulin pump without captor (4 weeks)

Inclusion Criteria:

• type I diabetic patients undr basal/prandial diet
• treated by insuline
• with no insuline pump during at least 3 months
• with HbA1C dosed during the 3 months before inclusion

Exclusion Criteria:

• minor patients
• pregnant woman
• already participating to another studies